Pharmacotherapy of tobacco dependence.
Smoking cessation activities and support for its implementation should be integrated into the health care system. The outcome of smoking cessation has improved with the availability of proper behavior approaches and medications. Incorporating these guidelines into daily clinical practice ensures that health care providers provide the opportunity for patients to quit smoking. The best hope of improved treatment comes from combining existing and new pharmacotherapies with effective behavioral therapy.
Talwar
Arunabh
A
Division of Pulmonary and Critical Care Medicine, Department of Medicine, 300 Community Drive, North Shore University Hospital, Manhasset, NY 11030, USA. arunabh@nshs.edu
Jain
Mukesh
M
Vijayan
V K
VK
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D009538:Nicotine / Q000008:administration & dosage* / Q000009:adverse effects; D018722:Nicotinic Agonists / Q000008:administration & dosage* / Q000009:adverse effects; D012907:Smoking / Q000503:physiopathology / Q000523:psychology; D016540:Smoking Cessation / Q000379:methods*; D014029:Tobacco Use Disorder / Q000188:drug therapy*; D014481:United States
D000316:Adrenergic alpha-Agonists; D018687:Antidepressive Agents, Second-Generation; D018722:Nicotinic Agonists; D016642:Bupropion; D009538:Nicotine; D003000:Clonidine